Antibody production in patients hospitalized with COVID-19

by Mary Ann Liebert, IncCredit: Mary Ann Liebert, Inc., publishersAntibody-secreting cells (ASCs) peaked at 3-4 weeks and were still being produced at 3-4 months in patients hospitalized with COV

Updated on: April 12,2024 20

Antibody production in patients hospitalized with COVID-19

by Mary Ann Liebert, IncCredit: Mary Ann Liebert, Inc., publishersAntibody-secreting cells (ASCs) peaked at 3-4 weeks and were still being produced at 3-4 months in patients hospitalized with COV

Updated on:April 12,2024 20

COVID vaccine induces robust T cell responses in blood cancer patients

by The Peter Doherty Institute for Infection and ImmunityGraphical abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.101017Researchers have found that, despite being h

Updated on: April 12,2024 19

COVID vaccine induces robust T cell responses in blood cancer patients

by The Peter Doherty Institute for Infection and ImmunityGraphical abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.101017Researchers have found that, despite being h

Updated on:April 12,2024 19

New class of antivirals works against broad range of RNA viruses including SARS-CoV-2

by Gillian Rutherford,University of AlbertaWnt/β-catenin pathway inhibitors enhance induction of type I and III interferons in response to viral infection. A549 cells were treated with DMSO alon

Updated on: May 09,2024 6

New class of antivirals works against broad range of RNA viruses including SARS-CoV-2

by Gillian Rutherford,University of AlbertaWnt/β-catenin pathway inhibitors enhance induction of type I and III interferons in response to viral infection. A549 cells were treated with DMSO alon

Updated on:May 09,2024 6

HIV: An antidiabetic drug to reduce chronic inflammation

by University of Montreal Hospital Research CentreScanning electromicrograph of an HIV-infected T cell. Credit: NIAIDMetformin, a drug used to treat type-2 diabetes, could help reduce chronic inflamma

Updated on: April 16,2024 17

HIV: An antidiabetic drug to reduce chronic inflammation

by University of Montreal Hospital Research CentreScanning electromicrograph of an HIV-infected T cell. Credit: NIAIDMetformin, a drug used to treat type-2 diabetes, could help reduce chronic inflamma

Updated on:April 16,2024 17

HIV: Reprogramming cells to control infection

by Pasteur InstituteMicroscopic image of an HIV-infected T cell. Credit: NIAIDCells from the rare individuals who naturally control HIV infection have been the focus of investigation for nearly 1

Updated on: April 16,2024 14

HIV: Reprogramming cells to control infection

by Pasteur InstituteMicroscopic image of an HIV-infected T cell. Credit: NIAIDCells from the rare individuals who naturally control HIV infection have been the focus of investigation for nearly 1

Updated on:April 16,2024 14

New compound offers hope for deadly tropical disease

byAmerican Society for Biochemistry and Molecular BiologyWhen praziquantel is used to treat human schistosomiasis, drug-resistant worms and juvenile worms continue to produce eggs. Each worm pai

Updated on: March 28,2024 0

New compound offers hope for deadly tropical disease

byAmerican Society for Biochemistry and Molecular BiologyWhen praziquantel is used to treat human schistosomiasis, drug-resistant worms and juvenile worms continue to produce eggs. Each worm pai

Updated on:March 28,2024 0

SARS-CoV-2 hijacks antiviral human proteins to enter human cells

by American Society for MicrobiologyTransmission electron micrograph of SARS-CoV-2 virus particles isolated from a patient. Credit: NIAIDSARS-CoV-2 depends on the broadly antiviral interferon-ind

Updated on: April 22,2024 20

SARS-CoV-2 hijacks antiviral human proteins to enter human cells

by American Society for MicrobiologyTransmission electron micrograph of SARS-CoV-2 virus particles isolated from a patient. Credit: NIAIDSARS-CoV-2 depends on the broadly antiviral interferon-ind

Updated on:April 22,2024 20

COVID-19: Vaccination and infection found to trigger differential immune responses

by Lena Bösch,University of GöttingenCredit: CC0 Public DomainIt was initially unclear how the immune system would react to infections with SARS-CoV-2 after a third vaccination. A team of scient

Updated on: April 10,2024 16

COVID-19: Vaccination and infection found to trigger differential immune responses

by Lena Bösch,University of GöttingenCredit: CC0 Public DomainIt was initially unclear how the immune system would react to infections with SARS-CoV-2 after a third vaccination. A team of scient

Updated on:April 10,2024 16

SARS-CoV-2 induces inflammation, cytokine storm and stress in infected lung cells

by Heinrich-Heine University DuesseldorfThe coronavirus SARS-CoV-2 docks with its spike protein onto the receptor-ACE2 found on the surface of lung cells. The levels of co-expressed genes with the hum

Updated on: April 22,2024 14

SARS-CoV-2 induces inflammation, cytokine storm and stress in infected lung cells

by Heinrich-Heine University DuesseldorfThe coronavirus SARS-CoV-2 docks with its spike protein onto the receptor-ACE2 found on the surface of lung cells. The levels of co-expressed genes with the hum

Updated on:April 22,2024 14

Republic of Congo reports its first mpox virus cases, in several regions

by Louis Patrick OkambaVials of single doses of the Jynneos vaccine for monkeypox are seen from a cooler at a vaccinations site on Aug. 29, 2022, in the Brooklyn borough of New York. The Republic of C

Updated on: March 20,2024 19

Republic of Congo reports its first mpox virus cases, in several regions

by Louis Patrick OkambaVials of single doses of the Jynneos vaccine for monkeypox are seen from a cooler at a vaccinations site on Aug. 29, 2022, in the Brooklyn borough of New York. The Republic of C

Updated on:March 20,2024 19

Type-I interferon stops immune system from 'going rogue' during viral infections

by McMaster UniversityCredit: CC0 Public DomainMcMaster University researchers have found not only how some viral infections cause severe tissue damage, but also how to reduce that damage.They ha

Updated on: April 16,2024 11

Type-I interferon stops immune system from 'going rogue' during viral infections

by McMaster UniversityCredit: CC0 Public DomainMcMaster University researchers have found not only how some viral infections cause severe tissue damage, but also how to reduce that damage.They ha

Updated on:April 16,2024 11

SARS-CoV-2 studies: Only neutralizing antibodies allow conclusions to be drawn about protection against new infections

by Medical University of ViennaPrinciple of cell-culture-based neutralization assays. (A) Conventional virus-neutralization test (VNT) and (B) pseudovirus-neutralization test (pVNT) are laborator

Updated on: April 22,2024 12

SARS-CoV-2 studies: Only neutralizing antibodies allow conclusions to be drawn about protection against new infections

by Medical University of ViennaPrinciple of cell-culture-based neutralization assays. (A) Conventional virus-neutralization test (VNT) and (B) pseudovirus-neutralization test (pVNT) are laborator

Updated on:April 22,2024 12